![Pharmaceuticals policy / Health care / Health / Pharmaceutical industry / Medical research / Healthcare quality / European Medicines Agency / European Union / Qualified Person Responsible For Pharmacovigilance / Marketing authorization / Summary of Product Characteristics / Pharmacovigilance Pharmaceuticals policy / Health care / Health / Pharmaceutical industry / Medical research / Healthcare quality / European Medicines Agency / European Union / Qualified Person Responsible For Pharmacovigilance / Marketing authorization / Summary of Product Characteristics / Pharmacovigilance](https://www.pdfsearch.io/img/2f55f7f4c1e5adc69e680d3547b3d090.jpg) Date: 2016-02-02 09:57:36Pharmaceuticals policy Health care Health Pharmaceutical industry Medical research Healthcare quality European Medicines Agency European Union Qualified Person Responsible For Pharmacovigilance Marketing authorization Summary of Product Characteristics Pharmacovigilance | | B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDvAdd to Reading ListSource URL: www.hma.euDownload Document from Source Website File Size: 225,29 KBShare Document on Facebook
|